Simplify Health Care ETF (PINK)
ARCA ARCA Primary Summary
PINK Chart
Why VSXY Is Gaining Momentum Across PINK and Beauty
VSXY's turnaround gains traction as bras, PINK, Beauty and international growth support stronger sales, margins and a cleaner operating model.
PINK's 58% Gains Since 2021 Come From Picking Winners, Not Owning Everything
Healthcare is supposed to be defensive. When tech stocks swing wildly and consumer spending wobbles, healthcare companies keep selling drugs, performing surgeries, and processing insurance claims.
Labor Smart, Inc. (OTC PINK: LTNC) and Upper Street Marketing, Inc. (UPPR) Unveil Visionary Partnership to Launch Casa Rica Tequila Nationwide
JACKSON, WY / ACCESSWIRE / January 15, 2025 / Labor Smart, Inc. (OTC PINK:LTNC), a leader in innovation and consumer-focused brand development, announces a transformative partnership with Upper Street Marketing, Inc. (UPPR) to introduce Casa Rica Tequila, a premium spirits brand celebrating the soul of Mexico. This launch signifies a major milestone, with Casa Rica Tequila debuting across 30 states, poised to set a new benchmark in the premium tequila category.
Simplify Health Care ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| RR rosemary richard WCG Wealth Advisors LLC | 503,148 | $18.41M | $19.69M | $1.27M | 6.9% |
 Christopher C. Powers Farther Finance Advisors, LLC | 1,553 | $56,840 | $60,396.17 | $3,556.17 | 6.26% |
 Alan Rosenfield HARMONY ASSET MANAGEMENT LLC | 29,037 | $955,410.52 | $1.13M | $174,709.52 | 18.29% |
| SC Stacey Cole Haven Private LLC | 49,135 | $1.5M | $1.92M | $423,557.55 | 28.26% |
| KD Keith Dwyer LeClair Wealth Partners LLC | 8,728 | $293,799 | $340,697.48 | $46,898.48 | 15.96% |
Simplify Health Care ETF (PINK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Simplify Health Care ETF ever had a stock split?
Simplify Health Care ETF Profile
| ARCA Exchange | US Country |
Overview
The fund described focuses primarily on investment in the U.S. health care sector, adhering to a strategy that mandates at least 80% of its assets—along with any funds borrowed for investment purposes—be invested in securities of U.S. health care companies. These companies are categorized under the Global Industry Classification Standard (GICS) health care sector. Typically, the fund's portfolio ranges from 50 to 100 different health care companies, showcasing a significant diversity within its investment approach. The aim of the fund is not only to invest in companies at the forefront of developing groundbreaking and effective medications but also in businesses that aim to economize or enhance the quality of health care systems. This dual focus suggests a balanced approach to investment, capitalizing on both innovative medical advancements and efficiency-driven health care solutions.
Products and Services
The fund's investment portfolio features a diverse array of products and services, aligning with its strategic focus on the health care sector. The primary offerings include:
- Securities of U.S. Health Care Companies: A significant share of the fund's investments is allocated towards securities owned by companies within the U.S. health care industry, adhering to the fund's mandate of investing at least 80% of its assets in this sector. This includes both equity and debt securities, chosen based on their potential to contribute towards the fund's growth and investment objectives.
- Development of Medicines: An important part of the portfolio is dedicated to companies involved in the research, development, and marketing of new and effective medicines. This includes biotechnology firms, pharmaceutical companies, and other entities engaged in drug development and innovation, aiming to address unmet medical needs and contribute to the health care landscape.
- Health Care System Efficiency: Alongside investments in medical innovation, the fund targets companies whose business models or products aim to reduce health care costs or improve the quality of care. This could involve companies specializing in health care technology, services that streamline patient care, or innovations that enhance operational efficiencies within health care systems.
Through a careful selection process and strategic emphasis on both innovation and efficiency, the fund aims to offer a balanced and diversified portfolio that holds potential for growth and positive impact within the U.S. health care sector.
